Reach Us +1 218 451 2974
Bridging Tau And Amyloid-? Pathologies In Sporadic Alzheimer?s Disease: Mitochondria Under The Spotlight | 21952
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Bridging tau and amyloid-? pathologies in sporadic Alzheimer?s disease: Mitochondria under the spotlight

2nd International Conference on Alzheimers Disease and Dementia

Diana F Silva, A Raquel Esteves and Sandra Morais Cardoso

YRF: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.008

Mitochondrial abnormalities have been widely described in several tissues in sporadic Alzheimer?s disease (sAD) patients and mild cognitive impairment (MCI) individuals. In 2004 Mitochondrial Cascade Hypothesis for sAD was proposed and asserts that inheritance determines baseline mitochondrial function and durability. When a particular mitochondrial functional threshold is reached within AD relevant neurons, the neurodegenerative process emerges. In this study, cells bearing mitochondrial DNA from MCI and AD subjects and age-matched controls, differentiated into neurons were used. It was hypothesize that mitochondrial dysfunction causes a microtubule network disruption through the activation of cytosolic SIRT2. This event leads to the decreased efficiency of autophagic-lysosomal pathway (ALP), which, in turn, favors Abeta production. It was observed that mitochondria from AD and MCI groups present reduced membrane potential, are fragmented and its biogenesis is compromised. It was also observed an alteration in mitochondrial mediated redox signalling with an overactivation of SIRT2 and a decrease in acetylated-tubulin levels. These events disrupted microtubule-dependent intracellular traffic in AD cells which potentiated the accumulation of damaged, dysfunctional mitochondria within autophagosomes. Interestingly, it was found that despite MCI cybrids containing abnormal mitochondria, the functional threshold was not reached since microtubule integrity is maintained and ALP is over-activated. MCI cells are still able to degrade dysfunctional mitochondria since there is no evident accumulation of mitochondrial proteins, in opposition to AD cells. Overall, as many of the changes observed in AD cells are also seen in AD subject brains, it can be conclude that cumulative alterations in mitochondrial function, present in very early AD stages, leads to synaptic dysfunction and neuronal loss when microtubule assembly becomes compromised.
Diana F Silvia is currently pursuing her PhD at Center for Neuroscience and Cell Biology at the University of Coimbra, Portugal. Since 2009 she has been interested on understanding the pathophysiologic mechanisms of Alzheimer?s disease from a mitochondrial point of view. She has been able to describe that mitochondrial dysfunction starts a sequence of events leading to cell demise in AD models, in a team work between the University of Coimbra and University ok Kansas Medical Center, USA. These observations can be accessed on more than 10 papers published in peer reviwed journals.
Relevant Topics